Imatinib mesylate
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
749 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 36 | 91 | 28 | 17 | 41 | 196 |
| Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 23 | 73 | 28 | 5 | 20 | 139 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 16 | 33 | 9 | 2 | 4 | 55 |
| Myeloid leukemia chronic-phase | D015466 | — | — | 9 | 20 | 8 | 4 | 7 | 45 |
| Philadelphia chromosome | D010677 | — | — | 3 | 9 | 2 | 2 | 2 | 15 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 5 | — | 1 | 2 | 10 |
| Covid-19 | D000086382 | — | U07.1 | — | 3 | 3 | 2 | — | 8 |
| Hematologic neoplasms | D019337 | — | — | 2 | — | — | 1 | — | 3 |
| Systemic mastocytosis | D034721 | — | C96.21 | 1 | 2 | — | 1 | — | 3 |
| Chromosome aberrations | D002869 | Orphanet_68335 | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 18 | 41 | 8 | — | 3 | 62 |
| Sarcoma | D012509 | — | — | 3 | 14 | 3 | — | — | 17 |
| Pulmonary arterial hypertension | D000081029 | — | — | 1 | 3 | 8 | — | 1 | 11 |
| Myeloid leukemia accelerated phase | D015465 | — | — | 6 | 4 | 1 | — | — | 9 |
| Glioblastoma | D005909 | EFO_0000515 | — | 2 | 4 | 2 | — | — | 8 |
| Residual neoplasm | D018365 | — | — | 1 | 4 | 1 | — | — | 5 |
| Myeloid leukemia | D007951 | — | C92 | 1 | 3 | 2 | — | — | 5 |
| Graft vs host disease | D006086 | — | D89.81 | 1 | 3 | 1 | — | — | 5 |
| Hematologic diseases | D006402 | EFO_0005803 | D75.9 | 1 | 2 | 1 | — | — | 3 |
| Pneumonia | D011014 | EFO_0003106 | — | — | 1 | 1 | — | — | 2 |
Show 11 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 13 | 18 | — | — | 4 | 32 |
| Melanoma | D008545 | — | — | 4 | 11 | — | — | — | 12 |
| Prostatic neoplasms | D011471 | — | C61 | 4 | 7 | — | — | — | 10 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 4 | — | — | 1 | 8 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 3 | 4 | — | — | 1 | 8 |
| Hypereosinophilic syndrome | D017681 | EFO_1001467 | D72.11 | 1 | 7 | — | — | 1 | 8 |
| Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | 5 | — | — | — | 7 |
| Central nervous system neoplasms | D016543 | — | — | 5 | 4 | — | — | — | 7 |
| Systemic scleroderma | D012595 | EFO_0000717 | M34 | 2 | 7 | — | — | — | 7 |
| Myelodysplastic syndromes | D009190 | — | D46 | 3 | 3 | — | — | — | 6 |
Show 99 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 11 | — | — | — | — | 11 |
| Hodgkin disease | D006689 | — | C81 | 2 | — | — | — | — | 2 |
| Leukemia myeloid chronic atypical bcr-abl negative | D054438 | — | C92.2 | 2 | — | — | — | — | 2 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | — | — | — | — | 1 |
| Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | — | — | — | 1 |
| Thrombocytosis | D013922 | HP_0001894 | D75.83 | 1 | — | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | — | 1 |
| Papillary thyroid cancer | D000077273 | — | — | 1 | — | — | — | — | 1 |
| Acute lung injury | D055371 | EFO_0004610 | — | 1 | — | — | — | — | 1 |
| Promyelocytic leukemia acute | D015473 | — | C92.4 | 1 | — | — | — | — | 1 |
Show 20 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 1 | 1 |
| Disease-free survival | D018572 | EFO_0000409 | — | — | — | — | — | 1 | 1 |
| Germ-line mutation | D018095 | — | — | — | — | — | — | 1 | 1 |
| Mastocytosis | D008415 | — | D47.09 | — | — | — | — | 1 | 1 |
| Triple negative breast neoplasms | D064726 | — | — | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 48,543 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
58,843 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use